In one paragraphArticle in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Camila Feitosa MagalhãesLaboratory of Neural Development and Regeneration, Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.ORCID http://orcid.org/0009-0007-3716-8017 Rafael de Freitas Azevedo-RepossiLaboratory of Neural Development and Regeneration, Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.ORCID http://orcid.org/0000-0002-6237-3043 Luana de Almeida-PereiraLaboratory of Neural Development and Regeneration, Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.ORCID http://orcid.org/0000-0002-2121-5292 Millena Costa CrisóstomoLaboratory of Neural Development and Regeneration, Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.ORCID http://orcid.org/0009-0000-5728-2254 Mariana Rodrigues PereiraLaboratory of Nervous System Chemical Signaling Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil.ORCID http://orcid.org/0000-0001-5579-992X Hilda Petrs-SilvaLaboratory of Gene Therapy and Viral Vectors, Carlos Chagas Filho Institute of Biophysics, Universidade Federal Do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-8961-2959 Lucianne Fragel-MadeiraLaboratory of Neural Development and Regeneration, Institute of Biology, Department of Neurobiology, Universidade Federal Fluminense, Niterói, Brazil. lfragel@id.uff.br.ORCID https://orcid.org/0000-0001-6747-2828 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Retinitis pigmentosa is a hereditary neurodegenerative disease characterized by gradual photoreceptor loss, often leading to blindness. The murine model Pde6b
Indexed as
AmidohydrolasesPhotoreceptor Cells, VertebrateRetinitis PigmentosaAnimalsBenzamidesCarbamatesDisease Models, AnimalEnzyme InhibitorsFatty Acid Amide HydrolasesMiceMice, Inbred C57BLMicrogliaRetinaAmidohydrolasesBenzamidesCarbamatescyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterEnzyme InhibitorsFatty Acid Amide HydrolasesAnandamideEndocannabinoid systemInherited retinopathyPhotoreceptor degenerationrd10 miceRetinal neuroprotection
Identifiers
PMID42429887
PMCPMC13354659
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390